Patents by Inventor Hyeon-Ji KIM
Hyeon-Ji KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250139903Abstract: Disclosed are a method and apparatus for generating identification information for a virtual space that are capable of supporting users in searching for a virtual space. The method of generating identification information for a virtual space includes: setting a plurality of crawling points for each crawling area in a three-dimensional virtual grid shape for a virtual space; collecting at least one of a street view image and an aerial view image in a preset direction at the crawling point; and generating a spatial descriptor for each of the crawling points from the collected image.Type: ApplicationFiled: October 28, 2024Publication date: May 1, 2025Inventors: Jae Ho KIM, Soo Rim YANG, Hyeong Jun JOO, Hyeon Ji KIM, So Hyun LEE
-
Publication number: 20250082592Abstract: The present invention relates to a pharmaceutical composition for the prevention, alleviation or treatment of muscular dystrophy, containing a ROR? activator JC1-40. A composition according to the present invention increases mitochondrial membrane potential, increases the number of mitochondria, and increases the expression or activity of mitochondria-related genes or proteins to thus increase biosynthesis of mitochondria, and is thus expected to be effective in the prevention, alleviation and treatment of muscular dystrophy.Type: ApplicationFiled: May 13, 2022Publication date: March 13, 2025Inventors: Mi-Ock LEE, Hyeung-Geun PARK, Hyeon-Ji KIM
-
Publication number: 20250058017Abstract: One embodiment of the present disclosure provides an extracellular matrix-based hybrid ink for 3D printing, the hybrid ink including an extracellular matrix having an amine group and a modified hyaluronic acid introduced with an ethylenically unsaturated bond functional group, in which the extracellular matrix and the modified hyaluronic acid are in a crosslinked state by a chemical bond formed between at least some of amine groups present in the extracellular matrix and the ethylenically unsaturated bond functional group present in the modified hyaluronic acid. According to an embodiment of the present disclosure, the hybrid ink has mechanical properties suitable for 3D printing through chemical crosslinking between the extracellular matrix and modified hyaluronic acid as constituents, and can control the drug release rate by adjusting the chemical crosslinking density.Type: ApplicationFiled: March 14, 2022Publication date: February 20, 2025Applicant: POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATIONInventors: Jin Ah JANG, Hyeon Ji KIM, Seung Hyeon HWANG
-
Publication number: 20250061111Abstract: A learning data set enhancing method comprises the steps of: determining a first initial learning data set comprising a first learning-purpose natural language query, database information regarding the database, and a first learning-purpose SQL query corresponding to the first learning-purpose natural language query; generating first novel database information regarding a first novel database having a different schema from the database by applying a first schema modification operation to the database; generating a first novel learning-purpose SQL query regarding the first novel database by applying a first SQL query synchronization operation corresponding to the first schema modification operation to the first learning-purpose SQL query; and determining a first novel learning data set comprising the first learning-purpose natural language query, the first novel database information, and the first novel learning-purpose SQL query.Type: ApplicationFiled: December 30, 2021Publication date: February 20, 2025Inventors: Wook Shin HAN, Hyuk Kyu KANG, Hyeon Ji KIM
-
Publication number: 20250042911Abstract: The present invention relates to a novel benzopyran derivative useful for preparing a drug for treating cancer, and more specifically, to a novel benzopyran derivative which is a micromolecule having a macrophage inhibitory effect and is useful for preparing a drug for cancer treatment. The drug particularly inhibits the differentiation of immune macrophages to stimulate the immune system, and thus is useful for treating immune-related cancers.Type: ApplicationFiled: July 1, 2022Publication date: February 6, 2025Inventors: Sung OH AHN, Byung Sun PARK, Tae ll LIM, Ji Soo SEO, Hyeon Ji KIM, Na Jin JUNG, Hyo Young KIM, Ki Cheol GIL, Hyeon Ju LEE
-
Patent number: 12180139Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.Type: GrantFiled: September 19, 2022Date of Patent: December 31, 2024Assignee: AMTIXBIO CO., LTD.Inventors: Ki Duk Park, Jong Hyun Park, Hyeon Ji Kim, Ye Rim Lee, Siwon Kim, Ji Won Choi, Seul Ki Yeon, Jong-Seung Lee, Yong-Sun Bahn, Eunji Cheong, Kyung-Tae Lee, Joohyeon Hong
-
Patent number: 12172945Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.Type: GrantFiled: September 19, 2022Date of Patent: December 24, 2024Assignee: AMTIXBIO CO., LTD.Inventors: Ki Duk Park, Jong Hyun Park, Hyeon Ji Kim, Ye Rim Lee, Siwon Kim, Ji Won Choi, Seul Ki Yeon, Jong-Seung Lee, Yong-Sun Bahn, Eunji Cheong, Kyung-Tae Lee, Joohyeon Hong
-
Patent number: 12129220Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.Type: GrantFiled: September 19, 2022Date of Patent: October 29, 2024Assignee: AMTIXBIO CO., LTD.Inventors: Ki Duk Park, Jong Hyun Park, Hyeon Ji Kim, Ye Rim Lee, Siwon Kim, Ji Won Choi, Seul Ki Yeon, Jong-Seung Lee, Yong-Sun Bahn, Eunji Cheong, Kyung-Tae Lee, Joohyeon Hong
-
Publication number: 20230169075Abstract: Disclosed is a natural language query processing apparatus comprising, a processor that receives a natural language query input by a user and generates a structured query based on the natural language query, wherein the processor, when generating the structured query based on the natural language query, generates the structured query using a natural language processing result for the natural language query, a schema relationship extracted based on a relationship between subdatabases in a database related to the natural language query, and a cross-attention result generated between the natural language processing result and the schema relationship.Type: ApplicationFiled: October 12, 2022Publication date: June 1, 2023Applicant: POSTECH Research and Business Development FoundationInventors: Wook Shin HAN, Hyuk Kyu KANG, Hyeon Ji KIM
-
Publication number: 20230111780Abstract: An embodiment of the present disclosure provides an extracellular matrix-based bioadhesive as an adhesive in the form of a composition including an extracellular matrix-containing hydrogel and a gelatin curing agent, wherein the extracellular matrix-containing hydrogel is gelatinized. Since the extracellular matrix-based bioadhesive according to an embodiment of the present disclosure has the same or similar rheological properties as gelatin, the bioadhesive has flowability at a temperature of 30° C. or higher and may be evenly and easily applied to a lesion site in the body. In addition, the extracellular matrix-based bioadhesive according to an embodiment of the present disclosure may adhere well to the lesion site because of a level of adhesive strength that is about 2 to 6 times higher than that of fibrin glue used as a commercial tissue adhesive.Type: ApplicationFiled: September 29, 2022Publication date: April 13, 2023Inventors: Hyeon Ji KIM, Je Hwan JANG, Won Il HAN, Joon Young KIM, Jin Ah JANG, Dong Woo CHO
-
Publication number: 20230067422Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.Type: ApplicationFiled: September 19, 2022Publication date: March 2, 2023Inventors: Ki Duk PARK, Jong Hyun PARK, Hyeon Ji KIM, Ye Rim LEE, Siwon KIM, Ji Won CHOI, Seul Ki YEON, Jong-Seung LEE, Yong-Sun BAHN, Eunji CHEONG, Kyung-Tae LEE, Joohyeon HONG
-
Publication number: 20230056812Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.Type: ApplicationFiled: September 19, 2022Publication date: February 23, 2023Inventors: Ki Duk PARK, Jong Hyun PARK, Hyeon Ji KIM, Ye Rim LEE, Siwon KIM, Ji Won CHOI, Seul Ki YEON, Jong-Seung LEE, Yong-Sun BAHN, Eunji CHEONG, Kyung-Tae LEE, Joohyeon HONG
-
Publication number: 20230053855Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.Type: ApplicationFiled: September 19, 2022Publication date: February 23, 2023Inventors: Ki Duk PARK, Jong Hyun PARK, Hyeon Ji KIM, Ye Rim LEE, Siwon KIM, Ji Won CHOI, Seul Ki YEON, Jong-Seung LEE, Yong-Sun BAHN, Eunji CHEONG, Kyung-Tae LEE, Joohyeon HONG
-
Patent number: 11479526Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.Type: GrantFiled: December 27, 2021Date of Patent: October 25, 2022Assignee: AMTIXBIO CO., LTD.Inventors: Ki Duk Park, Jong Hyun Park, Hyeon Ji Kim, Ye Rim Lee, Siwon Kim, Ji Won Choi, Seul Ki Yeon, Jong-Seung Lee, Yong-Sun Bahn, Eunji Cheong, Kyung-Tae Lee, Joohyeon Hong
-
Publication number: 20220218465Abstract: A modified extracellular matrix-based hydrogel according to an example of the present disclosure includes an extracellular matrix-denatured collagen conjugate formed by a Michael addition reaction between an extracellular matrix having an amine group and a denatured collagen into which an ethylenically unsaturated bond functional group is introduced. The modified extracellular matrix-based hydrogel according to the present disclosure exhibits enhanced mechanical properties (e.g., viscoelasticity) compared to the extracellular matrix hydrogel before modification. In addition, it shows a high cell viability when the bioink is prepared by encapsulating cells in a modified extracellular matrix-based hydrogel according to the present disclosure.Type: ApplicationFiled: October 15, 2021Publication date: July 14, 2022Inventors: Hyeon Ji KIM, Dong Woo CHO, Jin Ah JANG
-
Publication number: 20220144755Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.Type: ApplicationFiled: December 27, 2021Publication date: May 12, 2022Inventors: Ki Duk PARK, Jong Hyun Park, Hyeon Ji Kim, Ye Rim Lee, Siwon Kim, Ji Won Choi, Seul Ki Yeon, Jong-Seung Lee, Yong-Sun Bahn, Eunji Cheong, Kyung-Tae Lee, Joohyeon Hong
-
Publication number: 20180235912Abstract: The present invention relates to a novel use of a thiourea derivative and, more specifically, to a pharmaceutical composition for preventing or treating autoimmune diseases comprising a thiourea derivative as an active ingredient. The thiourea derivative according to the present invention can inhibit the transcription of inflammatory genes such as TNF-?, IL-1?, NOS2 and IL-6, and also can inhibit the activity or production of Th17 and increase the activity or production of a regulatory T cell (Treg). Thus, it is expected that the thiourea derivative may be usefully used in a pharmaceutical composition, a health food composition, etc. for the prevention, improvement or treatment of various autoimmune diseases including rheumatoid arthritis.Type: ApplicationFiled: August 12, 2016Publication date: August 23, 2018Applicant: SEOUL NATIONAL UNIVERSITY R & DB FOUNDATIONInventors: Mi Ock LEE, Hyeung Geun PARK, Mi-La CHO, Yong-Hyun HAN, Hyeon-Ji KIM, Jin-Sil PARK
-
Publication number: 20180199925Abstract: Disclosed is a plug for amniotic recovery including a body part which blocks a wounded part of an amniotic membrane to recover the wounded part and a shock-absorbing part which is provided at one end of at least one of both ends in an insertion direction of the body part to absorb a shock by external force.Type: ApplicationFiled: January 12, 2018Publication date: July 19, 2018Inventors: Hyeon Ji KIM, Hyun Sun KO, JinAh JANG, Jong Chui SHIN, Dong Woo CHO, Dong Heon HA
-
METHOD FOR PREPARING BIOCOMPATIBLE CORNEA AND DECELLULARIZATION COMPOSITION FOR BIOCOMPATIBLE TISSUE
Publication number: 20160303288Abstract: Disclosed is a method for preparing a biocompatible tissue, the method including: providing a cornea from a tissue source through corneal incision; decellularizing the provided cornea in purified water containing charcoal for a predetermined period of time; and post-treating the decellularized corneal extracellular matrix through stirring in a hypotonic solution, so that the charcoal is used as a decellularizing agent for the cornea, thereby allowing the regeneration of a corneal tissue like in the original corneal extracellular matrix, and the preparation of a cornea without an immune rejection response and a fast regeneration effect of a patient through transplantation of the cornea can be expected.Type: ApplicationFiled: April 18, 2016Publication date: October 20, 2016Inventors: Moon Nyeo Park, Dong Woo Cho, Young Mi Moon, Jinah Jang, Hyeon Ji Kim -
Publication number: 20130297358Abstract: An integrated ticket reservation method allows a customer to easily inquire about the entire reservation status of ticket resellers and reserve his/her desired tickets when there are a lot of ticket resellers for one kind of ticket, and a terminal and a server therefor implement the method. The terminal requests servers to provide reservation status information including seat status information, receives the requested reservation status information from the servers, indicates seat status information included in the reservation status information from each of the servers into a full seating chart for the reservation target, and displays the full seating chart on a screen.Type: ApplicationFiled: May 2, 2013Publication date: November 7, 2013Applicant: Samsung Electronics Co., Ltd.Inventor: Hyeon-Ji KIM